文献速递临床试验与 GCP流行病学与生物统计

阿托品联合丙泊酚与阿托品联合阿曲库铵苏芬太尼对新生儿非紧急插管氧饱和度的影响:随机临床试验

Effect of Atropine With Propofol vs Atropine With Atracurium and Sufentanil on Oxygen Desaturation in Neonates Requiring Nonemergency Intubation: A Randomized Clinical Trial.
PubMed 文献 · JAMA · 2018-01-01

这项多中心双盲随机临床试验比较了阿托品-丙泊酚与阿托品-阿曲库铵-苏芬太尼预给药在新生儿非紧急经鼻气管插管中的效果。阿托品-丙泊酚组操作时间更长、镇静质量优良率更低,但呼吸和肢体运动恢复更快,SpO2在60分钟内保持更好。

要点

  • 两组 prolonged desaturation 发生率无显著差异,但研究可能把握度不足。
  • 阿托品-丙泊酚组操作时间更长、镇静优良率更低(51.7% vs 92.6%)。
  • 阿托品-丙泊酚组呼吸和肢体运动恢复更快,SpO2维持更优。

核心结论

  • 在新生儿非紧急经鼻气管插管中,阿托品联合丙泊酚与阿托品联合阿曲库铵苏芬太尼的 prolonged desaturation 发生率无显著差异。
  • 研究可能把握度不足,需进一步研究。

研究设计与样本

  • 多中心、双盲、随机临床试验,2012-2016年在法国6个NICU进行,纳入173例需非紧急插管的新生儿。
  • 因研究套件过期和缺乏资金而中断;89例分配至阿托品-丙泊酚组,82例至阿托品-阿曲库铵-苏芬太尼组。
  • 采用意向性分析混合模型;171例(99%)完成试验。

关键数值与推荐

  • 主要结局:SpO2<80%持续>60秒。

临床怎么用

  • 两种预给药方案均可用于新生儿非紧急经鼻气管插管,主要氧饱和度结局无显著差异。
  • 阿托品-丙泊酚组恢复更快但操作时间更长、镇静质量较低,需权衡利弊。
  • 研究把握度不足,临床决策应结合个体情况。

局限性

  • 研究因套件过期和缺乏资金而提前中断,可能把握度不足。
  • 样本量有限(173例),可能无法检测临床重要差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Propofol or a combination of a synthetic opioid and muscle relaxant are both recommended for premedication before neonatal intubation but have yet to be compared. OBJECTIVE: To compare prolonged desaturation during neonatal nasotracheal intubation after premedication with atropine-propofol vs atropine-atracurium-sufentanil treatment. DESIGN, SETTING, AND PARTICIPANTS: Multicenter, double-blind, randomized clinical trial (2012-2016) in 6 NICUs in France that included 173 neonates requiring nonemergency intubation. The study was interrupted due to expired study kits and lack of funding. INTERVENTIONS: Eighty-nine participants were randomly assigned to the atropine-propofol group and 82 to the atropine-atracurium-sufentanil group before nasotracheal intubation. MAIN OUTCOMES AND MEASURES: The primary outcome was prolonged desaturation (Spo2 <80% lasting > 60 seconds), using intention-to-treat analysis using mixed models. Secondary outcomes assessed the characteristics of the procedure and its tolerance. RESULTS: Of 173 neonates randomized (mean gestational age, 30.6 weeks; mean birth weight, 1502 g; 71 girls), 171 (99%) completed the trial. Of 89 infants, 53 (59.6%) in the atropine-propofol group vs 54 of 82 (65.9%) in the atropine-atracurium-sufentanil group achieved the primary outcome (adjusted RD, -6.4; 95% CI, -21.0 to 8.1; P = .38). The atropine-propofol group had a longer mean procedure duration than did the atropine-atracurium-sufentanil group (adjusted RD, 1.7 minutes; 95% CI, 0.1-3.3 minutes; P = .04); a less frequent excellent quality of sedation rate, 51.7% (45 of 87) vs 92.6% (75 of 81; P < .001); a shorter median time to respiratory recovery, 14 minutes (IQR, 8-34 minutes) vs 33 minutes (IQR, 15-56 minutes; P = .002), and shorter median time to limb movement recovery, 18 minutes (IQR, 10-43 minutes) vs 36 minutes (IQR, 19-65 minutes; P = .003). In the 60 minutes after inclusion, Spo2 was preserved significantly better in the atropine-propofol group (time × treatment interaction P = .02). Of the atropine-propofol group 20.6% had head ultrasound scans that showed worsening intracranial hemorrhaging (any or increased intraventricular hemorrhage) in the 7 days after randomization vs 17.6% in the atropine-atracurium-sufentanil group (adjusted RD, 1.2; 95% CI, -13.1 to 15.5, P = .87). Severe adverse events occurred in 11% of the atropine-propofol group and in 20% of the atropine-atracurium-sufentanil group. CONCLUSIONS AND RELEVANCE: Among neonates undergoing nonemergency nasotracheal intubation, the frequency of prolonged desaturation did not differ significantly between atropine used with propofol or atropine used with atracurium and sufentanil. However, the study may have been underpowered to detect a clinically important difference, and further research may be warranted. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT01490580, EudraCT number: 2009-014885-25.

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Durrmeyer X, Breinig S, Claris O, et al. Effect of Atropine With Propofol vs Atropine With Atracurium and Sufentanil on Oxygen Desaturation in Neonates Requiring Nonemergency Intubation: A Randomized Clinical Trial. JAMA. 2018. PMID: 29715354. doi:10.1001/jama.2018.3708

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。